The BioPlex 2200 anti-CCP test, based on Axis-Shield’s anti-CCP technology, can be used for the early detection of rheumatoid arthritis. The assay measures anti-CCP (anti-cyclic citrullinated peptide antibodies), a novel marker that has been shown to have good specificity in the diagnosis of rheumatoid arthritis.
The measurement of these antibodies is claimed to have recently been cited as a key parameter in the definitive diagnosis of rheumatoid arthritis by the American College of Rheumatology.
The BioPlex 2200 system is an automated, random-access multiplex testing platform with an assay menu targeting autoimmune diagnostics and infectious diseases. The anti-CCP kit is pending clearance by the US FDA.
Phone: 0011 1 510 724 7000
Lonza 4D-Nucleofector LV Unit PRO electroporation unit
Lonza's 4D-Nucleofector LV Unit PRO is a next-generation, large-scale electroporation unit...
Cytek 25-Color Immunoprofiling Assay, cFluor Reagent Kit (18C)
The Cytek 25-Color Immunoprofiling Assay has been designed and optimised to provide a turnkey...
Bio-Rad Laboratories QX Continuum and QX700 series ddPCR platforms
The latest platforms complement Bio-Rad's existing QX ddPCR portfolio and offer users...
